Featured Research

from universities, journals, and other organizations

Virus shows promise for imaging and treating pancreatic cancer

Date:
September 15, 2011
Source:
American Association for Cancer Research
Summary:
Researchers are investigating a potential treatment and noninvasive imaging modality for pancreatic cancer that shows promise, according to researchers.

Researchers are investigating a potential treatment and noninvasive imaging modality for pancreatic cancer that shows promise, according to researchers at Memorial Sloan-Kettering Cancer Center in New York, N.Y., and Genelux Corporation in San Diego, Calif.

The vaccinia virus construct GLV-1h153, engineered to encode for the human sodium iodide symporter gene (hNIS), is a promising candidate for viro-therapy of cancer and for long-term noninvasive monitoring of therapeutic response via deep tissue imaging modalities such as positron emission tomography (PET). This virus construct can also be used for targeted radiotherapy, according to study results presented at the Second AACR International Conference on Frontiers in Basic Cancer Research, held Sept. 14-18, 2011, in San Francisco.

Dana Haddad, M.D., Ph.D., who at the time of the study was a postdoctoral research fellow at Memorial Sloan-Kettering Cancer Center and is now a resident at the Mayo Clinic in Scottsdale, Arizona, said GLV-1h153-treated pancreatic tumors from more than 50 mice were treated and imaged to provide insight into tumor therapeutic response.

The combination of GLV-1h153 and radioiodine (131I) was promising for targeted radiotherapy and destruction of pancreatic tumors.

"We expected that we would be able to noninvasively detect virus replication in tumors using this imaging system, but we could not predict the timing of this, how long we could repeat serial imaging and whether this would actually provide information about therapeutic response," said Haddad.

The researchers were initially discouraged when the PET signal in pancreatic tumors began to fade about two weeks after treatment with the virus, according to Haddad.

However, she said they investigated what could be the cause of this loss of signal and were "pleased to ascertain that it was likely due to tumor kill and necrosis." They found that hNIS-mediated radiouptake noninvasively imaged with PET initially provided information into the presence of viral replication in the tumor, and later provided insight into the therapeutic response and biological activity of cancer cells.

"When the tumor began to die due to the effects of the virus, the PET signal began to decrease," said Haddad.

"We were further pleased to observe that although tumor kill with a very low dose of virus was not very impressive, we could achieve potent tumor kill when we combined virus treatment with systemic radiotherapy. Using lower doses of virus and radiotherapy could minimize potential toxicity and side effects associated with both treatments," said Haddad.

Further study of viral and radiotracer dosing, and their effects on therapeutic response and imaging potential is currently being planned, said Haddad.


Story Source:

The above story is based on materials provided by American Association for Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

American Association for Cancer Research. "Virus shows promise for imaging and treating pancreatic cancer." ScienceDaily. ScienceDaily, 15 September 2011. <www.sciencedaily.com/releases/2011/09/110915131546.htm>.
American Association for Cancer Research. (2011, September 15). Virus shows promise for imaging and treating pancreatic cancer. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/09/110915131546.htm
American Association for Cancer Research. "Virus shows promise for imaging and treating pancreatic cancer." ScienceDaily. www.sciencedaily.com/releases/2011/09/110915131546.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Stone Fruit Listeria Scare Causes Sweeping Recall

Stone Fruit Listeria Scare Causes Sweeping Recall

Newsy (July 22, 2014) The Wawona Packing Company has issued a voluntary recall on the stone fruit it distributes due to a possible Listeria outbreak. Video provided by Newsy
Powered by NewsLook.com
Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Huge Schizophrenia Study Finds Dozens Of New Genetic Causes

Newsy (July 22, 2014) The 83 new genetic markers could open dozens of new avenues for schizophrenia treatment research. Video provided by Newsy
Powered by NewsLook.com
CDC Head Concerned About a Post-Antibiotic Era

CDC Head Concerned About a Post-Antibiotic Era

AP (July 22, 2014) Sounding alarms about the growing threat of antibiotic resistance, CDC Director Tom Frieden warned Tuesday if the global community does not confront the problem soon, the world will be living in a devastating post-antibiotic era. (July 22) Video provided by AP
Powered by NewsLook.com
Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins